Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.
Journal: American journal of hematology
Published: January 19, 2026
Bacillus Calmette-Guérin (BCG) immunotherapy reprograms CNS immunity and alters Alzheimer's biomarkers: results from two open-label clinical trials.
Journal: Communications medicine
Published: December 23, 2025
TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related Diseases.
Journal: International journal of molecular sciences
Published: May 14, 2025
Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer.
Journal: Oncoimmunology
Published: March 14, 2024
The spleen assumes a major role in blood glucose regulation in type 1 diabetes patients treated with BCG.
Journal: Scientific reports
Published: February 20, 2024
Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases.
Journal: iScience
Published: December 12, 2023
The benefits of clustering in TNF receptor superfamily signaling.
Journal: Frontiers in immunology
Published: May 19, 2023
Letter to the Editor Regarding "The Non-Significant Benefit of BCG Vaccination for the Treatment of Iranian Patients with Type 1 Diabetes up to 48 Weeks: A Controversial Result".
Journal: Medical journal of the Islamic Republic of Iran
Published: May 16, 2023
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 26, 2022
Last Updated: 09/26/2026